ORPHAN

Welcome to the Brand page for “ORPHAN”, which is offered here for The design is a globe.;in the statement column 1 line 8, immuno comprised should be deleted, and immunocomprised should be inserted.;pharmaceuticals for the treatment of rare diseases, in the field of cardiology, diseases affecting immunocompromised patients, genetic disorders, haematology, infectious diseases, metabolic disorders, oncology, pallative care, poison control, respiratory diseases, urology and psychiatric diseases;orphan;product research and development of prescription and over-the-counter drugs;.

Its status is currently believed to be active. Its class is unavailable. “ORPHAN” is believed to be currently owned by “Orphan Pharmaceuticals, U.S.A., Inc.”